[Federal Register: April 17, 1997 (Volume 62, Number 74)]

[Proposed Rules]              

[Page 18728-18730]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr17ap97_dat-13]

 

=======================================================================

-----------------------------------------------------------------------

 

DEPARTMENT OF HEALTH AND HUMAN SERVICES

 

Food and Drug Administration

 

21 CFR Part 589

 

[Docket No. 96N-0135]

RIN 0910-AA91

 

 

Substances Prohibited From Use in Animal Food or Feed; Animal

Proteins Prohibited in Ruminant Feed; Draft Rule; Availability

 

AGENCY: Food and Drug Administration, HHS.

 

ACTION: Availability of draft rule.

 

-----------------------------------------------------------------------

 

SUMMARY: The Food and Drug Administration (FDA) is announcing the

availability of a draft rule that would provide that animal protein

derived from mammalian tissues is a food additive subject to certain

provisions in the Federal Food, Drug, and Cosmetic Act. The agency is

making this draft available because of the complex scientific and

regulatory issues involved regarding transmissible spongiform

encephalopathies and ruminant feeds. The agency invites the public to

submit comments with questions and concerns about the draft.

 

DATES: Written comments must be received in the Dockets Management

Branch by 4:30 p.m. d.s.t. April 28, 1997.

 

ADDRESSES: Submit written comments to the Dockets Management Branch

(HFA-305), Food and Drug Administration, 12420 Parklawn Dr., rm. 1-23,

Rockville, MD 20857, or you may fax the comments to 301-594-3215.

 

FOR FURTHER INFORMATION CONTACT: George A. (Bert) Mitchell, Center for

Veterinary Medicine, Food and Drug Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301-827-5587.

 

SUPPLEMENTARY INFORMATION: In the Federal Register of January 3, 1997

(62 FR 552), FDA published a proposed rule that would prohibit the use

of protein derived from ruminant and mink tissues in ruminant feeds.

The agency took this action due to concerns about the

 

[[Page 18729]]

 

possible effects if transmissible spongiform encephalopathies,

especially bovine spongiform encephalopathy, were to be spread through

animal feed. (See the preamble to the January 3, 1997, proposal for a

full discussion of this issue.) After considering the comments on the

proposal, given the complex issues involved, the agency has decided to

make this draft available to the general public under Secs. 10.40(f)

and 10.80(d)(2). These provisions allow the agency to make this draft

available for discussion of questions and concerns about the draft. In

this instance, FDA is conducting this discussion by inviting written

comments with questions and concerns about the draft which will be

addressed in any final rule that is published. The agency emphasizes

that the draft rule does not represent final agency action or the

agency's final decision on this regulation.

    Interested persons may, on or before April 28, 1997, submit to the

Dockets Management Branch (address above) written comments regarding

this draft rule. Two copies of any comments are to be submitted, except

that individuals may submit one copy. Comments are to be identified

with the docket number found in brackets in the heading of this

document. Received comments may be seen in the office above between 9

a.m. and 4 p.m., Monday through Friday.

 

    Dated: April 15, 1997.

William B. Schultz,

Deputy Commissioner for Policy.

    The text of the draft rule is set forth below:

    For the reasons discussed in the preamble, FDA hereby issues a

draft rule that would amend 21 CFR part 589 as follows:

 

PART 589--SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED

 

    1. The authority citation for 21 CFR part 589 continues to read as

follows:

 

    Authority: Secs. 201, 402, 409, 701 of the Federal Food, Drug

and Cosmetic Act (21 U.S.C. 321, 342, 348, 371).

    2. New Sec. 589.2000 is added to subpart B to read as follows:

 

 

Sec. 589.2000  Animal proteins prohibited in ruminant feed.

 

    (a) Definitions. (1) Protein derived from mammalian tissues

means any protein-containing portion of mammalian animals,

excluding: Blood and blood products; gelatin (including amino acids

and dicalcium phosphate derived from gelatin); inspected and

processed meat products which have been cooked and offered for human

consumption (plate waste and used cellulosic food casings); milk

products (milk and milk proteins); and any product whose only

mammalian protein consists entirely of porcine protein.

    (2) Renderer means any firm or individual that processes

slaughter byproducts, animals unfit for human consumption, or meat

scraps. The term includes persons who collect such materials and

subject them to minimal processing, or distribute them to firms

other than renderers (as defined here) whose intended use for the

products may include animal feed. The term includes renderers that

also blend animal protein products.

    (3) Blender means any firm or individual which obtains processed

animal protein from more than one source or from more than one

species, and subsequently mixes (blends) or redistributes an animal

protein product.

    (4) Feed manufacturer includes manufacturers of complete and

intermediate feeds intended for animals, and includes on-farm in

addition to off-farm feed manufacturing and mixing operations.

    (5) Nonmammalian protein includes proteins from nonmammalian

animals.

    (6) Distributor includes distributors of complete and

intermediate feeds intended for animals.

    (7) Ruminant means any member of the order of animals which has

a stomach with four chambers (rumen, reticulum, omasum, and

abomasum) through which feed passes in digestion. The order

includes, but is not limited to, cattle, buffalo, sheep, goats,

deer, elk, and antelopes.

    (b) Food additive status. The Food and Drug Administration has

determined that protein derived from mammalian tissues for use in

ruminant feed is a food additive subject to section 409 of the

Federal Food, Drug, and Cosmetic Act (the act). The use or intended

use in ruminant feed of any material that contains protein derived

from mammalian tissues causes the feed to be adulterated and in

violation of the act, unless it is the subject of an effective

notice of claimed investigational exemption for a food additive

under Sec. 570.17 of this chapter.

    (c) Requirements for renderers that are not included in

paragraph (e) of this section. (1) Renderers that manufacture

products that contain or may contain protein derived from mammalian

tissues and that are intended for use in animal feed shall take the

following measures to ensure that materials identified in paragraph

(b) of this section are not used in the feed of ruminants:

    (i) Label the materials as follows: ``Do not feed to cattle or

other ruminants''; and

    (ii) Maintain records sufficient to track the materials

throughout their receipt, processing, and distribution and make the

copies available for inspection and copying by the Food and Drug

Administration.

    (2) Renderers described in paragraph (c)(1) of this section will

be exempted from the requirements of paragraphs (c)(1)(i) and

(c)(1)(ii) of this section if they:

    (i) Use exclusively a manufacturing method that has been

validated by the Food and Drug Administration to deactivate the

agent that causes transmissible spongiform encephalopathy (TSE) and

whose design has been made available to the public;

    (ii) Use routinely a test method that has been validated by the

Food and Drug Administration to detect the presence of the agent

that causes TSE's and whose design has been made available to the

public. Products found to contain the agent that causes TSE's shall

be labeled ``Not for Use in Animal Feed.'' Records of the test

results shall be made available for inspection by the Food and Drug

Administration; or

    (iii) Use exclusively a method for controlling the manufacturing

process that minimizes the risk of the TSE agent entering the

product and whose design has been made available to the public and

validated by the Food and Drug Administration.

    (3) Renderers described in paragraph (c)(1) of this section will

be exempted from the requirements of paragraph (c)(1)(ii) of this

section if they use a permanent method, approved by FDA, to make a

mark indicating the presence of the materials. If the marking is by

the use of an agent that cannot be detected on visual inspection,

the renderer must use an agent whose presence can be detected by a

method that has been validated by the Food and Drug Administration

and whose design has been made available to the public.

    (d) Requirements for protein blenders, feed manufacturers, and

distributors that are not included in paragraph (e) of this section.

(1) Protein blenders, feed manufacturers, and distributors that

manufacture, blend, process, and distribute products that contain or

may contain protein derived from mammalian tissues shall comply with

paragraph (c)(1) of this section.

    (2) Protein blenders, feed manufacturers, and distributors,

shall be exempt from paragraphs (d)(1) of this section if they:

    (i) Purchase animal products from renderers that certified

compliance with paragraph (c)(2) of this section or purchase such

materials from parties that certify that the materials were

purchased from renderers that certified compliance with paragraph

(c)(2); or

    (ii) Comply with the requirements of paragraph (c)(2) of this

section where appropriate.

    (3) Protein blenders, feed manufacturers, and distributors shall

be exempt from paragraph (c)(1)(ii) of this section if they:

    (i) Purchase animal protein products that are marked in

accordance with paragraph (c)(3) of this section or purchase such

materials from renderers that certified compliance with paragraph

(c)(3) of this section, or purchase such materials from parties that

certify that the materials were purchased from renderers that

certified compliance with paragraph (c)(3) of this section; or

    (ii) Comply with the requirements of paragraph (c)(3) of this

section where appropriate.

    (4) Pet food products that are sold or are intended for sale at

retail are exempt from the labeling requirements in paragraphs (c)

and (d) of this section. However, if the pet food products are sold

or are intended for sale as distressed or salvage items for possible

use in ruminant feed, then such products shall be labeled in

accordance with paragraphs (c) or (d) of this section, as

appropriate.

    (5) Copies of certifications as described in paragraphs (d)(2)

and (d)(3) of this section,

 

[[Page 18730]]

 

shall be made available for inspection and copying by the Food and

Drug Administration.

    (e) Requirements for persons that intend to separate mammalian

and nonmammalian materials. (1) Renderers, protein blenders, feed

manufacturers, distributors, haulers and others that manufacture,

process, blend and distribute both protein products derived from

mammalian tissues or feeds containing such products, and protein

products from other animal tissues or feeds containing such

products, and that intend to keep those products separate shall:

    (i) Comply with paragraphs (c)(1) or (d)(1) of this section as

appropriate except that the labeling requirement shall apply only to

products derived from mammalian (other than pure porcine) tissues or

feeds containing such products;

    (ii) In the case of a renderer, obtain nonmammalian or pure

porcine materials only from single-species facilities;

    (iii) Provide for measures to avoid commingling or cross-

contamination:

    (A) Maintain separate equipment or facilities for the

manufacture, processing, or blending of such materials; or

    (B) Use clean-out procedures or other means adequate to prevent

carry-over of protein derived from mammalian tissues into animal

protein or feeds that may be used for ruminants; and

    (iv) Maintain written procedures specifying the clean-out

procedures or other means, and specifying the procedures for

separating mammalian (other than pure porcine) materials from

nonmammalian materials from the time of receipt until the time of

shipment.

    (2) Renderers, blenders, feed manufacturers, and distributors

will be exempted from appropriate requirements of paragraph (e)(1)

of this section, if they meet the appropriate criteria for exemption

under paragraphs (c)(2) or (c)(3), and paragraphs (d)(2) or (d)(3)

of this section.

    (f) Requirements for establishments and individuals that are

responsible for feeding ruminant animals. Establishments and

individuals that are responsible for feeding ruminant animals shall

maintain copies of purchase invoices and labeling for all feeds

containing animal protein products received, and make the copies

available for inspection and copying by the Food and Drug

Administration.

    (g) Adulteration and misbranding. (1) Animal protein products,

and feeds containing such products, that are not in compliance with

paragraphs (c) through (f) of this section, excluding labeling

requirements, will be deemed adulterated under section 402(a)(2)(C)

or (a)(4) of the act.

    (2) Animal protein products, and feeds containing such products,

that are not in compliance with the labeling requirements of

paragraphs (c) through (f) of this section will be deemed misbranded

under section 403(a)(1) of the act.

    (h) Inspection; records retention. (1) Records that are to be

made available for inspection and copying, as required by this

section, shall be kept for a minimum of 2 years.

    (2) Written procedures required by this section shall be made

available for inspection and copying by the Food and Drug

Administration.

[FR Doc. 97-10132 Filed 4-15-97; 3:17 pm]

BILLING CODE 4160-01-F